Literature DB >> 16510861

Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study.

David V Espino1, Oralia V Bazaldua, Raymond F Palmer, Charles P Mouton, Michael L Parchman, Toni P Miles, Kyriakos Markides.   

Abstract

BACKGROUND: Numerous methods have been used to evaluate medication management quality in older adults; however, their predictive validities are unknown. Major medication quality indicators include polypharmacy, drug-drug interactions, and inappropriate medication use. To date, no study has attempted to evaluate the three approaches systematically or the effect of each approach on mortality in a Hispanic population. Our objective was to evaluate the relationship between polypharmacy, drug-drug interactions, and inappropriate medication use on the mortality of a community-based population of Mexican American older adults.
METHODS: We used a life table survival analysis of a longitudinal survey of a representative sample of 3,050 older Mexican Americans of whom 1,823 were taking prescription and over-the-counter medications.
RESULTS: After adjustment for relevant covariates, use of more than four different medications (polypharmacy) was independently associated with mortality. The presence of major drug interactions and the use of inappropriate medications were not significantly associated with mortality in our study sample.
CONCLUSION: Polypharmacy (>4 medications) is significantly associated with mortality in Mexican American older adults. This community-based study is the first to demonstrate a direct association between polypharmacy and mortality in this population.

Mesh:

Year:  2006        PMID: 16510861     DOI: 10.1093/gerona/61.2.170

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  35 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

2.  Potentially Inappropriate Medication and Health Care Outcomes: An Instrumental Variable Approach.

Authors:  Chi-Chen Chen; Shou-Hsia Cheng
Journal:  Health Serv Res       Date:  2015-11-25       Impact factor: 3.402

3.  Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors.

Authors:  S J Lubinga; E Uwiduhaye
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

4.  Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study.

Authors:  Wan-Hsuan Lu; Yu-Wen Wen; Liang-Kung Chen; Fei-Yuan Hsiao
Journal:  CMAJ       Date:  2015-02-02       Impact factor: 8.262

Review 5.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

6.  Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation.

Authors:  Wei Terk Chang; Stefan R Kowalski; Wassana Sorich; Christopher P Alderman
Journal:  Int J Clin Pharm       Date:  2017-05-26

7.  Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Authors:  Alex Secora; G Caleb Alexander; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

8.  Variation over time in the association between polypharmacy and mortality in the older population.

Authors:  Kathryn Richardson; Alexandrine Ananou; Louise Lafortune; Carol Brayne; Fiona E Matthews
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

9.  Medication Exposure and Health Outcomes in Older Patients with End-Stage Kidney Disease: A Prospective Study Undertaken in New Zealand.

Authors:  Sashika Samaranayaka; Robert J Walker; Ari Samaranayaka; Sarah Derrett; John W B Schollum
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

10.  Factors associated with use of calcium and calcium/vitamin D supplements in older Mexican Americans: Results of the Hispanic EPESE study.

Authors:  David V Espino; S Liliana Oakes; Kathleen Owings; Kyrakos S Markides; Robert Wood; Johanna Becho
Journal:  Am J Geriatr Pharmacother       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.